(Q38158952)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Claire Seedhouse

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

William Atiomo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Mohamad Nasir Shafiee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Gulafshana Khan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Rina Ariffin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jafaru Abu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Caroline Chapman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Suha Deen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

David Nunns

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

30 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

248-253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24183733%20AND%20SRC:MED&resulttype=core&format=json

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Polycystic ovary syndrome and endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Evaluating the association between endometrial cancer and polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Altered protein expression in endometrial carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Understanding the benefit of metformin use in cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

In reply: risk factors for developing endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Endometrial atypical hyperplasia and subsequent diagnosis of endometrial cancer: a retrospective audit and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Endometrial hyperplasia and the risk of progression to carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Reproducibility of biopsy diagnoses of endometrial hyperplasia: evidence supporting a simplified classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Prevalence and clinical predictors of endometrial hyperplasiain anovulatory women presenting with amenorrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Diagnosis and management of endometrial hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Incidence of endometrial hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Prospective evaluation of insulin resistance among endometrial cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes--a potential model for PCOS-related insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Effects of metformin on mammalian target of rapamycin in a mouse model of endometrial hyperplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Metabolic syndrome and endometrial cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Dose-dependent insulin regulation of insulin-like growth factor binding protein-1 in human endometrial stromal cells is mediated by distinct signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Chemopreventive effects of metformin on obesity-associated endometrial proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Endometrial expression of Cyr61: a marker of estrogenic activity in normal and abnormal endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Deregulation of tissue homeostasis in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Chemoprevention meets glucose control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Comparison of antiproliferative effects of metformine and progesterone on estrogen-induced endometrial hyperplasia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028

Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.028